BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34909513)

  • 1. Towards CRISPR powered electrochemical sensing for smart diagnostics.
    Priya Swetha PD; Sonia J; Sapna K; Prasad KS
    Curr Opin Electrochem; 2021 Dec; 30():100829. PubMed ID: 34909513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas and Argonaute-Based Biosensors for Pathogen Detection.
    Yang Z; Mao S; Wang L; Fu S; Dong Y; Jaffrezic-Renault N; Guo Z
    ACS Sens; 2023 Oct; 8(10):3623-3642. PubMed ID: 37819690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases.
    Kabay G; DeCastro J; Altay A; Smith K; Lu HW; Capossela AM; Moarefian M; Aran K; Dincer C
    Adv Mater; 2022 Jul; 34(30):e2201085. PubMed ID: 35288985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas-powered nanobiosensors for diagnostics.
    Phan QA; Truong LB; Medina-Cruz D; Dincer C; Mostafavi E
    Biosens Bioelectron; 2022 Feb; 197():113732. PubMed ID: 34741959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Point of Care CRISPR-Based Diagnostics: From Method to Device.
    Chen H; Zhou X; Wang M; Ren L
    J Funct Biomater; 2023 Feb; 14(2):. PubMed ID: 36826896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
    Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
    ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustered Regularly Interspaced short palindromic repeats-Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives.
    Xie Y; Li H; Chen F; Udayakumar S; Arora K; Chen H; Lan Y; Hu Q; Zhou X; Guo X; Xiu L; Yin K
    Adv Sci (Weinh); 2022 Dec; 9(34):e2204172. PubMed ID: 36257813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-based electrochemical biosensors: an alternative for point-of-care diagnostics?
    Wachholz Junior D; Kubota LT
    Talanta; 2024 Jun; 278():126467. PubMed ID: 38968657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.
    Dai Y; Wu Y; Liu G; Gooding JJ
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20754-20766. PubMed ID: 32521081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-based Biosensors for Human Health: A Novel Strategy to Detect Emerging Infectious Diseases.
    He Y; Hu Q; San S; Kasputis T; Splinter MGD; Yin K; Chen J
    Trends Analyt Chem; 2023 Nov; 168():. PubMed ID: 37840598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease.
    Liu X; Hussain M; Dai J; Li Y; Zhang L; Yang J; Ali Z; He N; Tang Y
    Biol Proced Online; 2022 Jan; 24(1):2. PubMed ID: 35067222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas13a-Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification-Free miRNA Diagnostics.
    Bruch R; Baaske J; Chatelle C; Meirich M; Madlener S; Weber W; Dincer C; Urban GA
    Adv Mater; 2019 Dec; 31(51):e1905311. PubMed ID: 31663165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and bioapplication of CRISPR-based one-step, quantitative and multiplexed infectious disease diagnostics.
    Shen Y; Hu K; Yuan M; Duan G; Guo Y; Chen S
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36813257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ultrasensitive CRISPR/Cas12a based electrochemical biosensor for Listeria monocytogenes detection.
    Li F; Ye Q; Chen M; Zhou B; Zhang J; Pang R; Xue L; Wang J; Zeng H; Wu S; Zhang Y; Ding Y; Wu Q
    Biosens Bioelectron; 2021 May; 179():113073. PubMed ID: 33581428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas-Based MicroRNA Biosensors.
    Zhang Q; Zhang X; Zou X; Ma F; Zhang CY
    Chemistry; 2023 Mar; 29(16):e202203412. PubMed ID: 36477884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.